Cardiovascular Disease· Topic 2.3 Ischemic heart disease· 2.3.5

Non-ST-elevation myocardial infarction (NSTEMI)

Non-ST-elevation myocardial infarction is acute myocardial injury from partial or intermittent coronary occlusion, diagnosed by ischemic symptoms and a rising troponin without diagnostic ST elevation. Management is antiplatelet and anticoagulant therapy with risk stratification (TIMI or GRACE) guiding the timing of an invasive coronary strategy.

6 min read9 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: non-ST-elevation myocardial infarction (NSTEMI) is acute myocardial injury from partial or intermittent coronary occlusion, part of the non-ST-elevation acute coronary syndrome spectrum.

  • Epidemiology

    The most common ACS presentation in contemporary practice.

  • Risk factors

    Atherosclerotic risk factors: smoking, diabetes, hypertension, dyslipidemia, and family history.

  • Pathophysiology

    Non-occlusive thrombus: plaque rupture or erosion causes a partial or intermittently occlusive thrombus, or distal embolization, producing subendocardial ischemia.

  • Clinical features

    Chest pain: pressure-like substernal discomfort, often at rest, prolonged, or in a crescendo pattern.

  • Differential diagnosis

    STEMI: ischemic symptoms with diagnostic ST elevation, distinguished by persistent ST-segment elevation on ECG mandating immediate reperfusion, absent in NSTEMI (STEMI).

  • Diagnosis

    Establish with the Fourth Universal Definition of MI in the absence of ST elevation: a rise and/or fall of troponin with at least one value above the 99th-percentile upper reference limit plus…

  • Management

    First, give dual antiplatelet and anticoagulant therapy: Aspirin 325 mg chewed then 81 mg PO daily indefinitely.

  • Complications

    Recurrent infarction and refractory ischemia.

  • Prognosis

    Substantial short-term risk: of reinfarction and death, quantified by TIMI and GRACE scores.

  • Prevention

    Intensive secondary prevention: aspirin, high-intensity statin to an LDL goal below 70 mg/dL (often lower), dual antiplatelet therapy for the recommended duration, and risk-factor control.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.